Core Viewpoint - Stryker's stock experienced a 9.46% decline due to a viral Reddit post about a cyberattack, but the company's strong fundamentals indicate resilience and growth potential [1] Financial Performance - Stryker reported $25 billion in annual revenue, achieving an 11.4% growth in Q4 2025 [1] - The company beat earnings estimates in all four quarters of 2025 and expanded adjusted operating margins by at least 100 basis points for the second consecutive year [1] - Free cash flow increased to $4.28 billion, reflecting a 23% year-over-year growth [1] Market Sentiment - The bearish sentiment on Reddit was driven by a single post regarding a cyberattack, which is not indicative of Stryker's overall business health [1] - Analyst consensus remains positive, with a price target of $424.89 compared to the current price of $337, supported by 22 buy or strong buy ratings and no sell ratings [1] - Engagement on Reddit regarding Stryker is classified as "low," indicating minimal retail investor interest [1] Future Outlook - CEO Kevin Lobo expressed confidence in entering 2026 with "significant momentum," projecting organic growth of 8% to 9.5% and adjusted EPS of $14.90 to $15.10 for the full year [1] - The Mako robotic surgery platform set installation records in Q4, and the Inari Medical acquisition contributed to a 58.1% year-over-year growth in the Vascular segment [1]